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COVID-19 is a novel (new) coronavirus fatal disease caused by SARS-COV-2 
(2019-nCoV). The outbreak of this pandemic first has been identified in Wuhan, 
Hubei Province, China on 1 December 2019, and has spread worldwide very 
quickly. It is now a major global health threat. After the World War II, the world 
faces such a major challenge in health sector and economy. The virus is 
transmitted human-to-human through the respiratory system. From the poor to the 
rich, infants to old, every people are infected from this virus. The disease spreads 
in Italy very fast and the north of the country is mostly affected. Lombardy Region 
is the most infected region in the country. An attempt has been made here to 
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1.  Introduction 
 
Italy is a unitary parliamentary republic and official name is Italian Republic. Its 
capital city is Rome and official language is Italian. It is a European country 
consisting of a peninsula delimited by the Alps and surrounded by several islands. 
It is located in south-central Europe, and considered a part of Western Europe 
(Figure 1). Its total area is 301,340 km2 (116,350 mile2). Population density is 206 
per square km. It borders with France, Switzerland, Austria, Slovenia, and the 
enclave microstates of Vatican City and San Marino. In 2020, its total population 
become 60,461826 (91.5% Italians Ethnic groups and 8.5% others); third-most 
populous member state of the EU. Of them 78% are Roman Catholic, 15% 
Irreligious and 7% others. Life expectancy is 84 years by birth (86 years for female 
and 81.9 for male), which is the 5th in the world (after Hong Kong, Japan, 
Switzerland, and Singapore) (Country Profile, 2020). 
 
Coronaviruses (CoV) are a large family of non-segmented, enveloped, positive-
sense, single-stranded RNA viruses that typically cause mild to severe respiratory 
disease in humans. COVID-19 is a new illness that is caused by a virus called 
SARS-CoV-2 (Figure 2) (Centers for Disease Control and Prevention, CDC, 
2020). On 11 February 2020, the International Committee on Taxonomy of Viruses 
(ICTV) named the COVID-19 virus as “Severe Acute Respiratory Syndrome 
Coronavirus 2 (SARS-CoV-2)” as the name of the new virus which causes 
COVID-19 (ECDC, 2020). 
 
Up to March 2020, Italy has become the most hit of pandemic COVID-19 outbreak 
country outside of Asia (Remuzzi & Remuzzi, 2020). According to Government of 
Italy (GoI) and the Italian National Institute of Health (Istituto Superiore di Sanità 
(ISS)), a total infected case on 9 April is 139,400 with 17,700 deaths, and the 
region with the highest number of cases is Lombardy, which registered 53,414 
with 9,722 deaths. The other infected regions on 9 April are Emilia-Romagna 
(18,238 with 2,234 deaths), Piedmont (13,883 with 1,378 deaths), Veneto (12,410 
with 739 deaths), Tuscany (6,379 with 392 deaths), Liguria (4,906 with 654 
deaths), Marche (4,859 with 652 deaths), Lazio (4,266 with 244 deaths), Campania 
(3,268 with 221 deaths), Apulia (2,634 with 219 deaths), Autonomous Province of 
Trento (2,602 with 255 deaths), Friuli-Venezia Giulia (2,218 with 169 deaths), 
Sicily (2,159 with 133 deaths), Abruzzo (1,859 with 179 deaths), Autonomous 
Province of Bolzano (1,835 with 183 deaths), Umbria (1,289 with 50 deaths), etc. 
On 15 May 2020, infected regions in Italy are Lombardy (84,342 with 16,000 
deaths), Piedmont (29,370 with 3,400 deaths), Emilia-Romagna (27,100 with 3,955 
deaths), Veneto (18,880 with 1,764 deaths), Tuscany (9,890 with 982 deaths), 
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Liguria (9,080 with 1,345 deaths), Lazio (7,330 with 610 deaths), Marche (6,618 




Figure 1: Map of Italy. 
 
The mostly infected people are older than 50 years. On 9 April it is the third 
highest number of COVID-19 infected country and first in deaths. Death rate of 
Italy as of 9 April, 2020, by age group are 0-19 (0.1%), 20-29 (0.1%), 30-39 
(0.4%), 40-49 (0.9%), 50-59 (2.4%), 60-69 (9%), 70-79 (23.4%), 80-89 (31.2%), 
90+ (26.7%) (Statista, 2020). 
 





Figure 2: Shape of SARS-CoV-2. Source: (CDC, 2020). 
 
On 11 February 2020, the World Health Organization (WHO) named the zoonotic 
coronavirus disease as COVID-19 (“CO” stands for “corona”, “VI” for “virus” and 
“D” for “disease”, while “19” for the year), which belongs to the sarbecovirus 
subgenus of Coronaviridae family, subfamily Coronavirinae (Enserink, 2020). It is 
more contagious than both SARS-CoV (outbreaks in 2003, China) and MERS-
CoV (outbreaks in 2012, Middle-East) (Wang et al., 2020a). On 20 March 2020, 
Italy becomes the second-largest COVIT-19 infected country, after China and 
considers a serious threat to the Italian national health system. The health 
department of the country has limited capacity of Intensive Care Unit (ICU) 
(Saglietto et al., 2020). Depending on the fatality of 9 and 11 March 2020, the GoI 
takes progressive mitigation attempts, such as limits social interactions to prevent 
virus diffusion (Remuzzi & Remuzzi, 2020). 
 
Minor to major symptoms of this illness are fever (>100.4°F/38°C), dry cough, 
fatigue, sputum production, dyspnoea, shortness of breath, lymphopenia, anorexia, 
headache, hypoxemia, chills, nausea or vomiting, rhinorrhoea, muscle or joint pain, 
grand-glass opacities, myalgia, haemoptysis, sore throat, sneezing, nasal 
congestion, RNAaemia, diarrhea, etc. Sometimes the symptoms transform to 
pneumonia (infection of the lungs), multi-organ failure (e.g., kidney, heart, etc.), 
and even to death. The period from the onset of COVID-19 symptoms to death 
ranged from 6 to 41 days with a median of 14 days (Carlos et al., 2020; Huang et 
al. 2020; Mohajan, 2020; Ren, et al., 2020; Wang et al., 2020a). However, some 
people who have been infected with COVID-19 experienced no symptoms. Some 
patients experienced loss of taste, appetite or smell (Culp, 2020). 
 
On 30 January, the WHO declared the outbreak a “Public-Health Emergency of 
International Concern (PHEIC)” as the outbreak could spread to countries with 
fragile health systems (Callaway, 2020). On 11 March 2020, the WHO declared 
the global outbreak as a pandemic to minimize the infection and mortality rate 
(WHO, 2020b).  




Older age, cardiovascular disease, diabetes, chronic respiratory disease, asthma, 
hypertension, and cancer are all associated with an increased risks of death from 
infection of COVID-19 in Italy (Yang et al., 2020). Obesity and smoking are also 
increase risks of death (Wang et al., 2020b). In Italy higher risks have also been 
reported in men than in women (Livingston & Bucher, 2020). 
  
At present Italy is experiencing a pandemic of COVID-19 which emerged in the 
Lombardy region, Northern Italy. The virus of this fatal disease has come to Italy 
through foreign tourists or non-residents and the Italian citizens who travel abroad 
(Day, 2020). 
 
Lethality (infected fatality rate (IFR)) of COVID-19 is very high in Italy compared 
with other major infected countries, such as the USA, Spain, China, the UK, 
France, the Netherlands, Iran, etc. Sometimes asymptomatic contacts spread 
COVID-19 largely. For example, estimated asymptomatic proportion was 18% for 
the outbreak on the Diamond Princess Cruise ship in Japan (Mizumoto et al., 
2020). The disease is so widespread and there is no plausible reason of this high 
IFR. On 24 March 2020, case fatality rate (CFR) of Italy was 10%; and the 
corresponding figures of Spain, China and Germany were 7.2%, 4%, and 0.5% 
respectively (Villa, 2020). 
 
 
2. Literature Review 
 
Matteo Villa has compared the case fatality rate (CFR) and infected fatality rate 
(IFR) of SARS-CoV-2 in Italy. He shows that CFR (about 10%) is higher and 
faster than in other countries of Europe. But relying on this figure will be 
misleading for measuring the fatality rate of this disease. He shows that the CFR is 
not a good measure of plausible lethality of COVID-19 in Italy (Villa, 2020). 
Marta Paterlini points out that the COVID-19 outbreak is having catastrophic 
effects on the Italian economy, which is likely to plunge into a recession, as well as 
social and psychological effects on the population (Paterlini, 2020). Ashleigh R. 
Tuite, Victoria Ng, Erin Rees, and David Fisman try to estimate COVID-19 
outbreak size in Italy based on international case exportations. They have 
identified 46 cases of COVID-19 reported in 21 countries in Europe, Africa, North 
America, and South America which were either in individuals with recent travel 
from Italy, or who had presumed infection by a traveler from Italy (Tuite et al., 
2020). 
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Martin Enserink and Kai Kupferschmidt estimate that as the new COVID-19 
infections and deaths are increasing exponentially; the USA, Italy, Spain, the UK, 
France, and Netherlands will need twice as many ICU beds as estimated previously 
(Enserink & Kupferschmidt, 2020). In editorials report Rachel E. Jordan, Peymane 
Adab, and K. K. Cheng observe that in Italy, higher risks have been reported in 
men than in women due to their higher smoking rates and subsequent 
comorbidities (Jordan et al., 2020). Guzzetta Giorgio and his coauthors indicate 
that three regions Lombardy, Emilia Romagna and Veneto are most affected 
regions of COVID-19 from February to March in Italy. They have projected the 
number of COVID-19 cases in 593 municipalities of Lombardy where at least one 
case of community transmission had been recorded by 8 March 2020 (Giorgio et 
al., 2020). 
 
Andrea Saglietto and his coauthors show epidemic curves for European 18 
countries. They urge that all European countries accept the Italian lesson of high 
fatality and immediately adopt very restrictive measures to limit viral diffusion, 
ensure appropriate health system response, and reduce mortality (Saglietto et al., 
2020). Andrea Remuzzi and Giuseppe Remuzzi indicate that China has reduced the 
new infections by more than 90% of COVID-19; this reduction is not the case 
elsewhere, such as in the USA, Italy, the UK, Spain, France, and Brazil. They 
confirm that the maximum number of infected patients reaches in Italy and the 
maximum number of patients require ICU admission (Remuzzi & Remuzzi, 2020).  
 
Neil M. Ferguson and his coauthors assess non-pharmaceutical interventions to 
reduce contact rates in the population and reduce transmission of the virus. They 
apply a previously published micro-simulation model to two countries; the UK and 
the USA. They advise to follow the strategies of suppression that was possible in 
the short-term in China and South Korea. According to them two fundamental 
strategies are; i) mitigation, which focuses on slowing but not necessarily stopping 
epidemic spread–reducing peak healthcare demand while protecting those most at 
risk of severe disease from infection, and ii) suppression, which aims to reverse 
epidemic growth, reducing case numbers to low levels and maintaining that 
situation indefinitely  (Ferguson et al., 2020). Victor M. Corman and his coauthors 
stress on real-time Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) to 
detect causative viruses from respiratory secretions in public health laboratories 
during international health emergencies by coordination between public and 
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3. Methodology of the Study 
 
Research is the process of collecting, analyzing, and interpreting the data in order 
to understand a phenomenon. Methodology is merely the study of a particular 
method, or methods, for reaching a desired end in a continuous procedure (Leedy 
& Ormrod, 2001). According to C. R. Kothari research methodology is the 
systematic procedure adopted by researchers to solve a research problem that maps 
out the processes, approaches, techniques, research procedures, and instruments. It 
may be understood as a science of studying how research is done scientifically 
(Kothari, 2004). Reliability and validity are necessary conditions for a good 
research and these are maintained to present this study in a concise, but precise 
manner (Mohajan, 2017; 2018). To prepare this article we have used the secondary 
data. The data are collected and designed the article from previous published 
articles, books of famous authors, websites, theses, conference papers, case studies, 
various statistical data, and various research reports.  
 
The methodology of this article is to discuss the aspects of pandemic outbreak of 
COVID-19 in Italy. In this study we have tied to discuss the background and 
transmission of COVIT-19, and healthcare system to cure patient from this 
pandemic disease in Italy. We also indicate high risk people in the country, and 
prevention and treatment techniques to face COVIT-19 efficiently. 
 
On 9 April 2020, total infections in Italy reached to 139,400 with 17,700 deaths; on 
16 April the corresponding figures become respectively 168,941 and 22,170. On 
15 May 2020, total infections in the country became 223,096, total recovered 
115,288 and total deaths reached to 31,368 (Worldometer, 2020). 
 
 
4. Objective of the Study 
 
The main objective of this study is to create consciousness of COVID-19 among 
the people of Italy. The other objectives are as follows: 
• to highlight the pandemic of this disease, 
• to provide the fatality of COVID-19 in Italy, and  
• to analyze the transmission, prevention, and treatment techniques of the 
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5. Background  
 
On 1 December 2019, the COVID-19 has been identified in a person who had not 
had any exposure to the Huanan Seafood Wholesale Market of Wuhan, Hubei 
Province of China, has spread quickly nationwide and globally. It is a new illness 
that is caused by a virus called SARS-CoV-2. It has not been previously found in 
people and spread globally from China through human-to-human contact (WHO, 
2020a). Three human coronaviruses; SARS-CoV (outbreak in 2003), MERS-CoV 
(outbreak in 2012), and SARSCoV-2 (outbreak in 2019) are thought to spread from 
infected animals-to-people through contact (Guarner, 2020; Wang et al., 2020a). 
 
The diseases spread outward from Hubei Province at the late December 2019 (Li et 
al., 2020). The first confirmed death was on 9 January 2020 in Wuhan. The first 
death outside China occurred in the Philippines, and the first death outside Asia 
was in France. On 31 January 2020, two Chinese tourists were found positive 
COVID-19 in Rome, Italy (Holm & Moritsugu, 2020). On 30 January, the WHO 
declared the outbreak a “Public-Health Emergency of International Concern 
(PHEIC)” as the outbreak could spread to countries with fragile health systems 
(Callaway, 2020). On 11 March 2020, the WHO declared the global outbreak as a 
pandemic to minimize the infection and mortality rate (WHO, 2020b). On 5 April 
total infected people reached to 1,225,360 and total deaths became 66,542 
worldwide. Italy is the most vulnerable in the world and on 5 April total infected 
people in this country reached to 1,225,360 and total deaths became 66,542. On 8 
April 2020, total 209 countries and territories around the world are affected; global 
total infection reached to 1,455,987, total recovered 310,108, and total death 
became 83,687. In Italy the corresponding figures became 135,586; 24,392; and 
14,555. On 16 April 2020, total infection in Italy became about 168,941 with 
22,170 deaths. On 15 May 2020, total infections in the country became 223,096, 
total recovered 115,288 and total deaths reached 31,368 (Worldometer, 2020).  
 
 
6. Transmission of COVIT-19  
 
The virus is transmitted mainly from person-to-person in close contact with others. 
Respiratory droplets transform from infected person by talking, coughing or 
sneezing; touching an object or surface with the virus on it and then touching 
mouth or eyes before washing hands. Droplets only stay suspended in the air for a 
short time. Minimum personal distance between two people becomes one meter (3 
feet) (Chan, et al., 2020; WHO, 2020a). The COVID-19 infected patients were 
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confirmed by RT-PCR kit diagnosis system performed using nasopharyngeal 
swabs (Corman et al., 2020). 
 
 
6.1 Spread of COVID-19 in Italy 
 
On 31 January 2020, two Chinese (a Chinese couple) tourists were found positive 
COVID-19 in Rome. On that day the GoI suspended all flights to and from China 
and declared a state of emergency with the duration of six months and introduced 
thermal scanners and temperature checks on international passengers arriving at 
Italian airports (Corriere Della Sera, 2020). On 6 February 2020, an Italian man 
backed to Italy from the city of Wuhan, China, confirmed as the third case in Italy 
(Onder et al., 2020). 
 
 
6.2 Spread in Lombardy Region 
 
In the night of 20 February 2020, the first case (a 38 year old man, marathon 
runner) of COVID-19, local transmission was confirmed in the intensive care unit 
(ICU) in the Hospital of Codogno, Lodi, Lombardy Region (a district of 10 million 
people), Italy. He had a history of a typical pneumonia that was not responding to 
treatment (Bai et al., 2020). He can breathe on his own after more than two weeks 
in ICU for severe pneumonia. By the following day, 21 February 2020, about 28 
positive cases were identified and later an initial outbreak was identified around 
the city of Codogno (Cereda et al., 2020). On 22 February 2020, a 77 year old 
woman died in Lombardy, first death in Italy (Giurida & Beaumont, 2020).  
 
 
6.3 Spread in Mainland of Italy 
 
By the beginning of March, the virus had spread to all regions of Italy. The disease 
appears to have a much higher severity in Italy than elsewhere. The number of 
infected patients increases at the exponential rate. On 28 February 2020, there were 
over 530 infections and on 8 March the figure became 5,830. On 8 March 2020, 
the GoI expanded the quarantine to all of Lombardy and 14 other northern 
provinces, and on the following day to all of Italy, placing more than 60 million 
people in quarantine. On 11 March 2020, Conte prohibited nearly all commercial 
activity except for supermarkets and pharmacies. On 15 March 2020, infected 
more than 24,747 people (2,026+ healthcare staff) and 1,809 deaths; the fatality 
rate of Italy became 7.2, which was higher than in China (3.8) (Paterlini, 2020). On 
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19 March 2020, Italy became the country with the highest number of confirmed 
deaths in the world. On 21 March 2020, all non-essential businesses and industries 
are closed and enforced restrictions to movement of people. On 30 March 2020, 
the total of confirmed cases becomes 101,739 with 11,591 deaths, and 14,620 
recoveries. On 3 April total infected people became 115,200 and total deaths 
13,915. On 5 April total infected people became 124,632, total recovered 20,996, 
and total deaths became 15,362. On 16 April 2020, total infection in Italy became 
about 168,941 with 22,170 deaths. On 15 May 2020, total infections in the country 
became 223,096, total recovered 115,288 and total deaths reached to 31,368 
(Worldometer, 2020).  
 
 
6.4 Most Infected Areas 
 
The disease appears to have a much higher severity in Italy than elsewhere. 
Lombardy, the region around Milan is the most affected in Italy. It has about 1,000 
beds for patients of ICU. March 5, about 72% positive cases were observed in the 
provinces of Bergamo, Lodi, and Cremona (Paterlini, 2020). On 9 April most 
infected regions are Lombardy (53,414 with 9,722 deaths), Emilia-Romagna 




7. Healthcare System in Italy 
 
In Italy the number of patients infected since 21 February and the infection 
increases exponentially. Italy has about 5,200 beds for intensive care units (ICUs). 
Of those, as of 11 March 2020, about 1,028 are already filled by patients with 
SARS-CoV-2 infection. It is estimated that more than 4,000 hospital beds will be 
needed by mid-April, 2020. To decrease Italian outbreak, the country must follow 
strategy of China (Remuzzi & Remuzzi, 2020). After infection of 24,747 people 
(including 2,026 healthcare providers) and killed off 1,809; GoI imposed state of 
emergency lockdown from northern Italy to the whole country. The country is 
experiencing a chronic shortage of healthcare workers. On 9 March the GoI 
announced a plan to add 20,000 new doctors, nurses, and hospital employees to 
meet the demand (WHO, 2020c). 
 
Healthcare providers have been working day and night since 20 February and of 
them about 20% have become infected, and some have died. On 11 March 2020, 
according to the Istituto Superiore di Sanità (ISS) about 12,462 patients were 
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infected and 827 died. Those who died had diabetes, cardiovascular diseases, or 
cancer, or were smokers. Of them age boundary: 14·1% were 90+, 42·2% were 
80–89, 32·4% were 70–79, 8·4% were 60–69, and 2·8% were 50–59 (Cereda et al., 
2020; Tuite et al., 2020).  
 
 
8. High Risk People 
 
All people of Italy are in the risk of COVID-19. From infant to old every people 
are infected from this disease. Older people whose ages are more than 50 years 
with weakened immune systems are infected tremendously. In 2019, 
approximately 23% of the Italian population was aged 65 years or older. So that, 
higher case fatality rate of Italy is higher than other countries (Onder et al., 2020). 
The patients of hypertension, cardiovascular disease, chronic respiratory illness, 




9. Prevention and Treatment  
 
To heal from the COVID-19 there is no vaccine or antibiotic. Treatment consists of 
supportive care and relief of symptoms. Supportive treatments are; i) rest isolate, 
ii) take pain and fever medications except aspirin, iii) drink plenty of liquids, iv) 
use a room humidifier, and v) take a hot shower to help ease a sore throat and 
cough. Other supportive treatments for critically ill patients are supplemental 
oxygen, fluid administration, being managed in intensive care units (ICUs) and 
receiving rescue therapies, such as extracorporeal membrane oxygenation (Center 
for Health Security, 2020; Mohajan, 2020). 
 
Prevention is the best way to protect this virus (CDC, 2020). The prevention 
techniques are as follows (Kampf et al., 2020; Mohajan, 2020; UK, 2020; WHO, 
2020d):  
• Wash hands vigorously with soap and water for at least 20 seconds after 
going to the toilet, after coughing and sneezing, before and after caring for 
an ill person, after caring healthy or sick animals, before preparing and 
serving foods, and before eating. After hand washing, dry with tissue, clean 
towel or hand dryer. Hand washing must continue at least one time in an 
hour even a person is at home.    
• If soap and water is not available, use a 62–71% alcohol-based hand 
sanitizer. 
Malaysian Journal of Medical and Biological Research, Volume 7, No 2/2020, pp. 56-66. 
12 
 
• Avoid close contact, such as kissing, sharing cups, or sharing eating utensils 
with sick people.  
• Isolate quarantine at home or hospital if anybody feels sick. 
• Cover nose and mouth with a tissue when coughing or sneezing, cannot use 
this tissue for several times and throw the tissue in the covered trash 
immediately. 
• Avoid touching eyes, nose, or mouth with unwashed hands. 
• Avoid hand shaking. 
• Avoid contact with sick animals and infected people if possible. Use PPEs if 
care them. 
• Wash hands after animal contact and after visiting farms, markets, barns, 
petting zoos and agricultural fairs, and then touch the nose, eyes or mouth. 
• Maintain healthy habits, such as get enough exercise, a well-balanced diet, 
eat healthy foods, thoroughly cooked meat and animal products, drink 
sufficient water and fruit juices, get sufficient sleep, manage stress, and 
avoid smoking and alcohol taking. 
• If any healthy person has traveled from an affected area, there may be 
restrictions on movements for up to 2 weeks. 
• Clean and disinfect objects (e.g., doorknobs, desks, counter parts (tops, 
keyboards, and mouse), light switches, water tap, phones, toys, railings of 
stairs, etc.), touched surfaces, and clean floor where the patients stay.  
• Maintain at least one meter (3 feet) distance from other people at all times, 
not touching face with unwashed hands, etc. 
• Everybody infected or uninfected must cover nose and mouth with a tissue 
or a bent elbow when coughing. 
• Masks use who are infected with the virus, who are taking care of the 
patients, who go to any public place but no need for the healthy family 
members in home. Avoid touching the mask while using it, remove the mask 
using the lace from behind, do not touch the front of a mask and do not reuse 
single use masks. 
 
 
10. Conclusions and Recommendations 
 
In this study we have tried to discuss the pandemic outbreak of COVID-19 in Italy. 
In Europe the country has gained the experience of more infections and more 
deaths. The Lombardy region is the most affected area in the country. Hand 
washing, maintain healthy habits, masks use, and supportive treatment can reduce 
the fatality of this disease in Italy. 




Italy has a high proportion of older patients and COVID-19 deaths are mainly 
observed among older and male patients who also have multiple comorbidities. 
Since the people of Italy have captured the prevention techniques and supportive 
treatments of COVIT-19. As the GoI have taken various steps to reduce the 
disease, we hope that both the infections and deaths will reduce in Italy in a very 
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